Pharmaceuticals
Latest
Pharmaceuticals
What Happened When Mark Cuban ‘Opened the Kimono’ on Drug Pricing?
Two years in, Cuban discussed the evolution of Mark Cuban Cost Plus Drug Company and why he picked the pharmaceutical industry to disrupt on a Business Group on Health podcast.
By Will Maddox
Pharmaceuticals
Cost Plus at CVS: Mark Cuban’s Drug Company Is Disrupting the Biggest Players in Healthcare
CVS Health announced a cost-plus model last week in a major win for drug price transparency.
By Will Maddox
Physicians
Supreme Court Ruling Means Texas Remains One of Five States in the Country Without Physician Dispensing
After no legislative movement, Texas physicians took their case to the courts to be able to directly dispense medications to their patients.
By Will Maddox
Pharmaceuticals
Plano’s Reata Pharmaceuticals Acquired by Biogen for $7.3 Billion
After suffering an FDA setback earlier this year, Reata has been busy commercializing its first drug to get to market that treats a rare degenerative neurological disorder.
By Will Maddox
Pharmaceuticals
Mark Cuban’s Drug Company Will Soon Be Selling Its Medicine Directly to Hospitals
With its pharmaceutical manufacturing license in place, the company is ironing out the logistics to get needed medicines sent to hospital and clinic partners.
By Will Maddox
Advertisement
Latest
Pharmaceuticals
Newsweek Calls Mark Cuban Cost Plus Drug Co. a ‘Medical Marvel’
The innovative pharmaceutical company is one of ten disruptive healthcare innovators named by the magazine.
By Will Maddox
Pharmaceuticals
From Devastation to Popping Champagne: Reata Pharmaceuticals’ Roller Coaster Year
The Plano-based drug company halted work on years of research this year while celebrating a major achievement.
By Will Maddox
marijuana
Texas Is Likely to Expand Medicinal Marijuana Laws, But Access Is Still an Issue
Texas law says the medicine can only be stored in one location, meaning patients sometimes have to wait for weeks for their prescriptions.
By Will Maddox
Pharmaceuticals
Signify Health CEO Kyle Armbrester on What’s Next After CVS’ $8 Billion Acquisition
Signify will be staying in Dallas, growing, and diversifying, he says. "This is not about cost-cutting."
By Will Maddox
Pharmaceuticals
Texas Pharmacists Want to Keep Their Expanded Vaccination Capabilities
Advocates are pushing for a law to codify pandemic-era changes, but pediatricians say kids need to get vaccinations from their medical home.
By Will Maddox